Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

New Market Research Report: Genmab A/S - Strategy and SWOT Report


Print article Print article
2014-04-04 14:36:32 - New Business research report from MarketLine is now available from Fast Market Research

Genmab A/S - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on Genmab A/S required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Genmab A/S in the form of a SWOT analysis
* An in-depth view of the business model of Genmab A/S including a breakdown and examination of key business segments
* Intelligence on Genmab A/S's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Genmab A/S,

such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- www.fastmr.com/prod/787935_genmab_as_strategy_and_swot_report.as ..

Highlights:

Genmab (or 'the company') is a biotechnology company engaged in the discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases. The company's therapeutic emphasis is in the areas of cancer, infectious diseases, rheumatoid arthritis and other inflammatory conditions. It is headquartered in Copenhagen, Denmark and employed 179 people as of December 31, 2012. The company recorded revenues of DKK484.6 million (approximately $83.7 million) during the financial year ended December 2012 (FY2012), an increase of 38.1% over FY2011. The operating loss of the company was DKK116.7 million (approximately $20.2 million) in FY2012, as compared to an operating loss of DKK249.4 million (approximately $43.1 million). The net loss was DKK487.1 million (approximately $84.1 million) in FY2012, as compared to a net loss of DKK596.4 million (approximately $103 million) in FY2011.

Reasons to Purchase:

* Gain understanding of Genmab A/S and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Genmab A/S as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Genmab A/S's business structure, strategy and prospects

Report Table of Contents:

Company Snapshot
Genmab A/S: Company Overview
Genmab A/S: Overview and Key Facts
Genmab A/S: Overview
Genmab A/S: Key Facts
Genmab A/S: Key Employees
Genmab A/S: Key Employee Biographies
Genmab A/S: Major Products and Services
Genmab A/S: Company History
Genmab A/S: Management Statement
Genmab A/S: Locations and Subsidiaries
Genmab A/S: Key Competitors
Genmab A/S: Company Analysis
Genmab A/S: Business Description
Genmab A/S: SWOT Analysis
Genmab A/S: SWOT Overview
Genmab A/S: Strengths
Genmab A/S: Weaknesses
Genmab A/S: Opportunities
Genmab A/S: Threats
Genmab A/S: Corporate Financial Deals Activity
Genmab A/S: Financial Deals Overview
Genmab A/S: Targets and Partners
Genmab A/S: Top Deals 2010 - 2014YTD*
Genmab A/S: Capital Raising
Genmab A/S: Partnership
Genmab A/S: Divestments
Genmab A/S: Private Equity and Ownership
Genmab A/S: Recent Developments
Genmab A/S: News and Events Summary
Genmab A/S: Business Expansion
Genmab A/S: Contracts
Genmab A/S: Corporate Governance
Genmab A/S: Financial Performance
Genmab A/S: Regulatory and Legal Events
Genmab A/S: Research & Development
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables

Table 1: Genmab A/S: Key Facts
Table 2: Genmab A/S: Key Employees
Table 4: Genmab A/S: Key Competitors
Table 5: Genmab A/S: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Genmab A/S: Deal Activity by Deal Type - Volume (2010 - YTD*2014)
Table 7: Genmab A/S: Targets and Partners
Table 8: Genmab A/S: Top Deals 2010 - 2014YTD*
Table 9: Genmab A/S: Capital Raising Volume and Value Trend (2010 - YTD*2014)
Table 10: Genmab A/S: Capital Raising by Deal Type (2010 - YTD*2014)
Table 11: Genmab A/S: Partnership Trend by Deal Type (2010 - YTD*2014)
Table 12: Genmab A/S: Divestments Volume and Value Trend (2010 - YTD*2014)
Table 13: Genmab A/S: Divestments by Geography (2010 - YTD*2014)
Table 14: Genmab A/S: Private Equity and Ownership Volume and Value Trend (2010 - YTD*2014)
Table 15: Genmab A/S: Private Equity and Ownership Volume by Deal Type (2010 - YTD*2014)
Table 16: Genmab A/S: News and Events Summary
Table 17: Genmab A/S: Business Expansion
Table 18: Genmab A/S: Contracts
Table 19: Genmab A/S: Corporate Governance
Table 20: Genmab A/S: Financial Performance
Table 21: Genmab A/S: Regulatory and Legal Events
Table 22: Genmab A/S: Research & Development

List of Figures

Figure 1: Genmab A/S: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Genmab A/S: Deal Activity by Deal Type - Volume (2010 - YTD*2014)
Figure 3: Genmab A/S: Capital Raising Volume and Value Trend (2010 - YTD*2014)
Figure 4: Genmab A/S: Capital Raising by Deal Type (2010 - YTD*2014)
Figure 5: Genmab A/S: Partnership Trend by Deal Type (2010 - YTD*2014)
Figure 6: Genmab A/S: Divestments Volume and Value Trend (2010 - YTD*2014)
Figure 7: Genmab A/S: Divestments by Geography (2010 - YTD*2014)
Figure 8: Genmab A/S: Private Equity and Ownership Volume and Value Trend (2010 - YTD*2014)
Figure 9: Genmab A/S: Private Equity and Ownership Volume by Deal Type (2010 - YTD*2014)

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com